Dual red-NIR luminescent EuYb heterolanthanide nanoparticles as promising basis for cellular imaging and sensing

Mater Sci Eng C Mater Biol Appl. 2019 Dec:105:110057. doi: 10.1016/j.msec.2019.110057. Epub 2019 Aug 5.

Abstract

The present work introduces ternary Ln(III) (Ln = Eu, Yb, Lu) complexes with thenoyltriflouro1,3-diketonate (TTA-) and phosphine oxide derivative (PhO) as building blocks for core-shell nanoparticles with both Eu(III)- or Yb(III)-centered luminescence and the dual Eu(III)-Yb(III)-centered luminescence. Solvent-mediated self-assembly of the complexes is presented herein as the procedure for formation of EuLu, EuYb and YbLu heterometallic or homometallic cores coated by hydrophilic polystyrenesulfonate-based shells. Steady state and time resolved Eu-centered luminescence in homolanthanide and heterolanthanide EuLu and EuYb cores is affected by Eu → Eu and Eu → Yb energy transfer due to a close proximity of the lanthanide blocks within the core of nanoparticles. The Eu → Yb energy transfer is highlighted to be the reason for the enhancement of the NIR Yb-centered luminescence. Efficient cellular uptake, low cytotoxicity towards normal and cancer cells, and sensing ability of EuYb nanoparticles on lomefloxacin additives via both red and NIR channels make them promising as cellular imaging agents and sensors.

Keywords: Cellular imaging; Dual luminescence; Energy transfer; Fluoroquinolones; Heterolanthanide nanoparticles; Mixed ligand complexes; Sensors.

MeSH terms

  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Cytotoxins* / chemistry
  • Cytotoxins* / pharmacology
  • Europium* / chemistry
  • Europium* / pharmacology
  • HeLa Cells
  • Humans
  • Luminescence*
  • Metal Nanoparticles* / chemistry
  • Metal Nanoparticles* / therapeutic use
  • Neoplasms* / diagnostic imaging
  • Neoplasms* / drug therapy
  • Ytterbium* / pharmacology

Substances

  • Antineoplastic Agents
  • Cytotoxins
  • Europium
  • Ytterbium